Skip to main content
Semler Scientific, Inc. logo

Semler Scientific, Inc. — Investor Relations & Filings

Ticker · SMLR ISIN · US81684M1045 LEI · 549300ZHL16S29QTW485 US Professional, scientific and technical activities
Open in API
Filings indexed 864 across all filing types
Latest filing 2014-07-29 Director's Dealing
Country US United States of America
Listing US SMLR

About Semler Scientific, Inc.

https://www.semlerscientific.com/

Semler Scientific, Inc. is a company that develops, manufactures, and markets technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. Its primary focus is on products and services that support the early detection and treatment of chronic diseases. The company's flagship product is a patented, FDA-cleared system that provides a rapid, point-of-care test to aid in the diagnosis of peripheral artery disease (PAD). In addition to its healthcare technology operations, the company has adopted a corporate strategy to acquire and hold bitcoin as its primary treasury reserve asset.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2014-07-29 English
FORM 4
Director's Dealing
2014-07-29 English
FORM 4
Director's Dealing
2014-07-29 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated July 25, 2014, by Semler Scientific, Inc. It announces the company's financial results for the second quarter and six months ended June 30, 2014, and includes a press release as an exhibit. The text explicitly states that the press release is furnished as Exhibit 99.1 and that the information is not deemed filed for certain regulatory purposes. The document is relatively short (3340 characters) and primarily serves as an announcement of the earnings release rather than containing the full financial results or detailed financial statements itself. According to the classification rules, initial announcements of quarterly or periodical financial results (key highlights only) correspond to the Earnings Release (ER) category. Therefore, this document should be classified as an Earnings Release (ER).
2014-07-25 English
OWNERSHIP DOCUMENT
Director's Dealing
2014-07-09 English
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated July 7, 2014, reporting the appointment of a new director and chairman of the Audit Committee. The content focuses on changes in the company's board of directors and senior management. There are no financial statements or detailed financial data presented, and the document is not an earnings release or annual report. The primary subject is the management change, which fits the category of Board/Management Information (MANG).
2014-07-08 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.